Table 1.

Patients’ demographic, clinical, and procedural data

Clinical and demographic data	Procedural data
Sex	Type of procedure (diagnostic or therapeutic)
Age	Urgency of procedure (elective or emergency)
Date and time of admission	Guidance (fluoroscopy, US, CT)
Symptoms at the time of procedure (fever, respiratory symptoms)	Oncological setting (procedures in non-oncologic patients—for benign diseases, procedures in oncologic patients—not focused on the tumor, oncological treatments–procedures focused on the tumor)
Symptoms during the last 15 days (fever, respiratory symptoms)	Treated body part (head, thorax, abdomen, bone, other)
Past medical history (previous or ongoing malignancy)	Ward of provenance (emergency department, intensive care unit, general wards)
Epidemiologic link (possible contact with COVID-19 subjects or coming from high-risk areas)	Delay between last diagnostic imaging and IR procedure (for emergency procedures)
Patient risk stratification*	Number of bedside US-guided procedures

*Patients were stratified into low risk/negative (no symptoms or epidemiologic link), intermediate risk/suspect (presence of symptoms at the time of procedure or during the previous 15 days, or epidemiologic link), high risk/suspect (presence of symptoms and epidemiologic link), and positive (positive test for SARS-CoV-2)